+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidiabetic"

From
From
From
From
Japan Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Japan Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 138 Pages
  • Japan
From
United Kingdom Diabetes Market Report: 2024-2032 - Product Thumbnail Image

United Kingdom Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 125 Pages
  • United Kingdom
From
Germany Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Germany Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 134 Pages
  • Germany
From
Russia Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Russia Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 133 Pages
  • Russia
From
China Diabetes Market Report: 2024-2032 - Product Thumbnail Image

China Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 131 Pages
  • China
From
Loading Indicator

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides. Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more